APO LET 2.5 (Letrozole 2.5 mg)
Pill with imprint APO LET 2.5 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Apotex Corp..
Letrozole is used in the treatment of breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO LET 2.5
Letrozole
- Imprint
- APO LET 2.5
- Strength
- 2.5 mg
- Color
- Yellow
- Size
- 7.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
-
hydroxypropyl cellulose (type h), hypromelloses, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 8000, sodium starch glycolate type A potato, titanium dioxide, ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 60505-3255 | Apotex Corp. |
| 68084-0803 | Amerisource Health Services |
More about letrozole
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 186 Reviews
- Drug class: aromatase inhibitors
Consumer resources
Other brands: Femara
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
